Long-term Results after Transfemoral Venous Thrombectomy for Iliofemoral Deep Venous Thrombosis  by Lindow, C. et al.
Eur J Vasc Endovasc Surg (2010) 40, 134e138Long-term Results after Transfemoral Venous
Thrombectomy for Iliofemoral Deep
Venous ThrombosisC. Lindow, A. Mumme, G. Asciutto, B. Strohmann, T. Hummel, B. Geier*Department of Vascular Surgery, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstrasse 56, 44791 Bochum, Germany
Submitted 31 August 2009; accepted 16 February 2010
Available online 1 April 2010KEYWORDS
Venous thrombectomy;
Long-term results;
Iliofemoral DVT;
Postthrombotic
syndrome* Corresponding author. Tel.: þ49(0
E-mail address: bruno.geier@rub.d
1078-5884/$36 ª 2010 European Socie
doi:10.1016/j.ejvs.2010.02.023Abstract Objective: In patients presenting with extensive venous thrombosis affecting the
pelvic veins, transfemoral venous thrombectomy has been suggested as an effective treatment
in selected patients.We present our experience of this technique as well as its long-term results.
Patients andmethods: Between January 1998 and January 2008, a total of 83 patients underwent
transfemoral venous thrombectomy in our Department of Vascular Surgery. In 22 cases, this was
combined with angioplasty and stenting of an iliac vein stenosis. Isolated intra-operative throm-
bolysis was performed in eight cases to treat deep venous thrombosis (DVT) affecting veins distal
to the common femoral vein. All patients suffered from a DVT involving the pelvic veins. A DVT
involving all venous segments from the pelvis to the calf was present in 63% of cases. Patients
were followed up at 3 months, 6 months and yearly thereafter by clinical and duplex ultrasound
examination.
Results: In all patients, the procedure was successful in achieving re-canalisation of the pelvic
veins at the end of the operation. Perioperatively, there was no mortality and there was no case
of clinically detected pulmonary embolism. Life-table analysis showed that, after a mean dura-
tion of 60 months following treatment,w75% of the treated venous segments remained patent.
Moderate post-thrombotic syndrome (PTS; clinical severity, etiology, anatomy and pathophysi-
ology (CEAP) C2eC4) was present in 20% of cases; severe PTS (CEAP C5 and C6) did not occur in
any of the treated patients.
Conclusions: It is safe and effective to treat extensive iliofemoral DVTusing transfemoral venous
thrombectomy and this prevents the development of severe PTS in the long term. The procedure
is only feasible in a subset of patients with DVT, depending on the extent and the age of the
thrombosis.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.) 2345093070; fax: þ49(0) 2345092272.
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Table 2 Characteristics of the 83 patients who underwent
venous thrombectomy. Thrombus age is defined as the time
interval between the onset of symptoms and treatment by
venous thrombectomy. The pelvic veins were thrombosed in
all 83 patients; the table summarises the extent of
involvement of other venous segments. Patient and
thrombus age are expressed as mean value and standard
deviation.
Age 52 S.D. 18 years
Sex Male/female 40/43
Localisation of DVT Left/right 63/20
Thrombus age (from onset
of symptoms)
4.5 S.D. 4.4 days
Extent of DVT Pelvic veins 100%
In addition: vena cava 22%
In addition: groin veins 94%
In addition: thigh veins 78%
In addition: calf veins 63%
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The treatment of deep venous thrombosis (DVT) has two
main goals: in the short term, to prevent acute complications
such as pulmonary embolism and caerulea phlegmasia dolens
and, in the long term, to avoid post-thrombotic syndrome
(PTS). Two different approaches may be used to reach these
goals: either conservative treatment using anticoagulation
in combination with external compression, leaving the
thrombus to be removedby the natural fibrinolytic activity of
the body; or invasive re-canalisation therapy, which involves
active removal of the thrombus, by either thrombolysis or
thrombectomy. In the presence of iliofemoral DVT, re-
canalisation techniques have regained popularity in recent
years since conservative management of extensive throm-
boses has limited efficacy in preventing PTS.
We present our department’s experience with venous
thrombectomy over the last decade and report the long-
term results of this technique.
Patients and methods
Between January 1998 and January 2008, a total of 83
patients underwent transfemoral venous thrombectomy in
the Department of Vascular Surgery, St. Josef Hospital,
Ruhr University, Bochum, Germany. Indications as well as
contraindications for the procedure are summarised in
Table 1. All patients suffered from a DVT involving the
pelvic veins. The initial diagnosis was made by duplex-
ultrasound. Subsequently, all patients underwent a compu-
terised tomography (CT) scan to assess the proximal extent
of the thrombosis and to check for involvement of the
inferior vena cava. The proximal and distal extent of the
thrombus in the pelvic region as well as the other patient
characteristics are summarised in Table 2. The table shows
that a DVT involving all venous segments from the pelvis to
the calf was present in 63% of cases. The mean time
interval between the onset of symptoms and treatment by
venous thrombectomy was 4.5 days.
The operations were carried out in a standardised
fashion under general anaesthesia and with the use of
a cell-saver auto-transfusion device. The common femoral
vein (CFV) was approached through a longitudinal incision
in the groin. After adequate dissection of the vessel,
5000 IU of heparin was given intravenously and the CFV was
clamped distally. A longitudinal venotomy was placed on
the anterior surface of the CFV and the iliac veins were
then cleared of thrombus with the help of a Fogarty cath-
eter. During the thrombectomy manoeuvre, positiveTable 1 Indications and contraindications for venous
thrombectomy.
Indications for
thrombectomy
Contraindications for
thrombectomy
Iliofemoral DVT Isolated DVT of calf- and/or
thigh-veins
Phlegmasia caerulea dolens Thrombus age> 10 days
DVT with embolisation
despite anticoagulation
Life expectancy< 10 years
Recurrent DVTpressure ventilation was applied and the patient was kept
in a head-up position. The patency of the iliac veins was
verified by intra-operative phlebography. In cases of
residual thrombi or residual stenosis, for example, caused
by an iliac spur, the iliac veins underwent angioplasty and
stenting (Figs. 1 and 2).
The thrombi in the distal venous segments in the leg and
in the thigh were removed passively by massaging and
elastic wrapping of the leg. Since 2006, we have also used
isolated intra-operative thrombolysis of the distal venous
segments using the technique described by Bla¨ttler et al.1
This included the intravenous injection of 20 mg recombi-
nant tissue plasminogen activator (rtPA) diluted in 1000 ml
Ringer solution via a foot vein. During the infusion, the CFV
remained clamped and, in addition, a tourniquet was
placed on the thigh as high as possible and inflated to
300 mmHg. The thrombolytic solution was left to act for
30 min; during this time the thrombectomy of the iliac veins
was carried out. The clamp on the CFV was moved proxi-
mally to the venotomy and the clots from the distal venousFigure 1 Setup for intraoperative thrombolysis with the
tourniquet applied to the thigh and an iv-line (wrapped in
sterile drapes) on the dorsum of the foot.
Figure 2 Intraoperative phlebography after venous throm-
bectomy and subsequent angioplasty and stenting of the left
common iliac vein for a residual stenosis caused by an iliac
spur. The patient was a 26 year old woman who was 3 months
pregnant and had suffered an extensive DVT affecting the
pelvic and leg veins on the left side.
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This was aided by massaging of the thigh and calf. The
venous blood was retrieved with the cell-saver and re-
transfused after processing.
Following closure of the CFV-venotomy, an arteriove-
nous (AV) fistula between the CFV and the femoral artery
was created. Typically, a tributary of the great saphenous
vein was anastomosed to the superficial femoral artery.
Intra-operatively, the patency of the AV fistula was
assessed by palpating for a thrill over the fistula.
Postoperatively, all patients received full anti-
coagulation, first with low-molecular-weight heparin and
then with coumadin for a minimum of 6 months. Patients
were advised to wear thigh-length class-2 compression
stockings during this period. The AV fistulas in the groin
were closed surgically after 3 months unless they had
occluded spontaneously.
Patients were followed up after 3 months, 6 months and
yearly thereafter. The follow-up workup consisted of
a clinical examination as well as a duplex-ultrasound
investigation of the pelvic and leg veins. During the clin-
ical examination, all signs of chronic venous hypertension in
the affected leg were recorded, that is, swelling, oedema,
varicose veins, skin changes and ulcers; in order to classify
the severity of the PTS using the clinical severity, aetiology,
anatomy and pathophysiology (CEAP) classification.2 CEAP
classes 2e4 were summarised as a moderate PTS, whereasa severe PTS constituted of CEAP classes 5 and 6. During the
duplex examination, particular care was taken to assess the
patency of the previously re-canalised pelvic veins. Patency
of the veins was assumed if duplex-ultrasound demon-
strated blood flow and if the vein was compressible.
The present study is a retrospective analysis of
prospectively acquired data. Life-table analysis was used to
evaluate the clinical success as well as the patency of the
treated venous segments over time.
Results
In all patients, the procedure was successful at restoring
patency of the pelvic veins at the end of the operation.
Angioplasty and stenting of the pelvic veins was carried out
in 22 cases (27%), and isolated intra-operative thrombolysis
was performed in eight cases (10%). In a total of nine cases,
no inguinal AV fistula was created, either because no suit-
able vein was found or because the operating surgeon
considered the fistula to be unnecessary.
There was no mortality perioperatively or during the in-
hospital stay and no case of clinically evident pulmonary
embolism was recorded, although we did not perform any
screening test to establish the true extent of this compli-
cation. In-hospital complications included re-thrombosis of
the treated venous segments in nine patients (11%) as well
as groin infections and/or haematomas in eight patients
(10%).
A total of 66 patients were followed up after a minimum
of 6 and a maximum of 118 months (median: 59 months).
Seventeen patients were lost to follow-up.
During the follow-up period, five patients experienced
symptomatic re-thrombosis of their previously reopened
venous segments with pain and swelling of the affected
limb. Again, there was no case of clinically relevant
pulmonary embolism. 27% of patients available for follow-
up went on wearing their compression stockings even after
the recommended 6 months. Typically, patients who
experienced some signs of PTS were likely to keep on
wearing their stockings while patients with good clinical
results and no PTS symptoms would usually stop wearing
compression stockings after 6 months. Life-table analysis
showed that, after a mean of 60 months postoperatively,
w75% of the treated venous segments remained patent
(Table 3). Moderate PTS with oedema, swelling and mild
skin changes (C2eC4) was present in 20% of cases (Table 4);
severe PTS with active or healed venous ulcers (C5 and C6)
did not occur in any of the treated patients.
Discussion
The popularity of active re-canalisation of major veins
occluded by thrombus using thrombolysis or thrombectomy
reached its peak in the mid-1980s. Since then, these treat-
ments have only been performed sporadically at a few
centres. This decline was mainly due to the invasiveness of
the treatment and high complication rates when compared
to anticoagulant treatment alone. In addition, the intro-
duction of low-molecular-weight heparin in the treatment of
DVT has led to a trend towards outpatient management of
DVT outside specialist centres, leading to a further increase
Table 3 Patency of the recanalised venous segments
during follow-up shown as a life table analysis. The bars
indicate the 95% confidence interval.
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Table 4 Incidence of moderate PTS (CEAP C2eC4) during
follow-up, shown as a life table analysis. The bars indicate
the 95% confidence interval. There was no case of severe
PTS during follow-up.
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Results after Transfemoral Venous Thrombectomy 137in conservative therapy.3,4 It is only in the last few years that
invasive re-canalisation techniques have regainedpopularity
and are considered to be a valid treatment option for ilio-
femoral DVT.5,6 There are numerous reasons for this: the re-
canalisation techniques have been refined and their
complication rates reduced while, at the same time, their
efficacy has been improved. In terms of thrombolytic
therapy, the introduction of catheter-directed regional
thrombolysis (CDT) has increased the rate of successful lysis
and significantly lowered the risk of systemic bleeding
complications.7 In addition, by combining pharmacological
thrombolysis with mechanical fragmentation of the
thrombus, it is possible to further improve the efficacy of
interventional DVT treatment.8
In the field of surgical thrombectomy, refinement and
improvement of the operative technique as well as the
combination with intra-operative angioplasty and stenting
of the pelvic veins have made it possible to treat extensive
DVTs involving the iliac veins and the vena cava from a small
groin incision while still achieving complete re-canalisation
of the venous system.1,9,10 The complication rates described
for this technique are low in particular, the rate of pulmo-
nary embolism is <1%, which is comparable to that seen
following conservative treatment. In our study group, we
did not observe any case of clinically detected pulmonary
embolism nor did we have any in-hospital deaths. The rate
of minor complications in our series, such as haematomas or
groin infections, was an acceptable 10%.
Another reason for the revived interest in active re-
canalisation techniques was the recognition that extensive
DVTs involving all venous segments have a worse outcome
when treated with anticoagulants alone using only conser-
vative therapy than the literature suggests.Most large studies
dealing with conservative therapy include patients with DVTs
of varied extent and, within these groups, patients with iso-
lated DVT of the lower leg and/or the thigh veins usually
constitute the majority.4 These limited thromboses typically
have a more benign course with a low risk of developing PTS
and are still best treated by anticoagulation alone.
However, looking at more extensive DVTs involving the
pelvic veins, a different picture evolves. Ziegler et al.11evaluated a group of 161 patients who had experienced
a DVT 10e20 years previously and found that the highest risk
for PTS was in patients with extensive thromboses involving
all venous segments. Asbeutahet al.12 lookedat patientswith
DVTs involving the pelvic segment and found that, after
a follow-up of 5 years, refluxwas present in the pelvic veins in
96% of cases and a severe PTS (CEAP 4e6) in 54% of cases.
It is these groups of patients, in particular, who seem to
benefit most from the active re-canalisation of their venous
system. In our study group, all patients had suffered from
a DVT involving the pelvic veins and 63% of them had a DVT
affecting all venous segments. In this particularly at-risk
group, we found mild PTS (CEAP C2eC4) in only 20% of
patients a mean of 5 years after treatment; severe forms of
PTS with active or healed venous ulcers were completely
absent.
These results are similar to those of other groups who
have reported on venous thrombectomy in the recent past.
Bla¨ttler et al.1 report their results in a group of 33 patients
and described a primary patency rate of 88%; after a follow-
up of 8 years, they found only three cases with mild PTS.
Venous ulcers did not occur in any of their patients.
Schwarzbach et al.10 described their results of venous
thrombectomy plus stenting of the pelvic veins in a group of
20 patients with iliofemoral and/or caval thromboses. After
a follow-up of 21 months, the primary and secondary
patency of the treated venous segments was 80% and 90%,
respectively, and an excellent clinical result was obtained
in 18 of the 20 patients. Hartung et al.9 used the same
technique to treat 29 patients with iliofemoral DVT; they
followed-up their patients after a mean of 63 months and
found a primary and secondary patency of 79% and 86%,
respectively, as well as good clinical results with very few
cases of mild PTS.
Local catheter-directed thrombolysis has been described
to achieve good results as well. Sillessen et al.13 used this
technique to treat 45 patients with iliofemoral DVT and had
initial success with re-opening thrombosed venous segments
in 93% of cases. After a follow-up of 2 years, they found
138 C. Lindow et al.normal venous function in 96% of patients. Of note, they did
experience complications needing treatment in 16% of cases
and their median lysis time was rather long at 71 h.
Gasparis et al.14 reported their experience with
pharmaco-mechanical thrombolysis in 14 patients and
achieved good or very good clinical results in 93% of cases.
All the results of active re-canalisation therapy for DVT
mentioned above are based on the experiences of select
centres with relatively small patient pools and, obviously,
do not have the evidence level of a prospective randomised
study. For catheter-directed thrombolysis, such a study
(TOLEDO) is underway in the USA and will, hopefully,
provide more information on the role of active re-
canalisation in the treatment of DVT.
In our department, venous thrombectomy has been the
treatment of choice for eligible patients with iliofemoral
DVT. However, with refinements of thrombolysis, there
might be subgroups of patients in which CDT is equally
effective. Venous thrombectomy still remains the treatment
of choice in patientswith contraindications for thrombolysis,
which, in our patient population, were roughly a third of the
patients. Furthermore, considering the rather prolonged
lysis times described in the literature, we would be more
inclined to use venous thrombectomy plus intra-operative
thrombolysis in patients with extensive DVT from the iliac to
the calf veins, and reserve CDT for patients with DVTs
involving only one or two venous segments.
In conclusion, our experience with venous thrombec-
tomy, in combination with angioplasty and stenting when
appropriate, indicates that it is a safe and effective tech-
nique to treat extensive iliofemoral DVT and prevents
progression to severe PTS in most cases. The procedure is
feasible only in a subset of patients: in addition to the
extent of the DVT, the other main determining factor is the
age of the thrombosis, since successful removal of the clots
is only possible up to a thrombus age of w10 days. We
believe that, in selected patients, active re-canalisation of
the venous system will continue to gain support.
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